Fred Alger Management’s BioTelemetry, Inc. BEAT Stock Holding History

Fred Alger Management’s Portfolio BEAT Stock Details BEAT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	–	Sell	-7,000	Closed	-$418K	–	590
2018 Q4	$418K	Buy	+7,000	New	+$420K	﹤0.01%	360
2018 Q3	–	Sell	-12,000	Closed	-$540K	–	599
2018 Q2	$540K	Buy	+12,000	New	+$479K	﹤0.01%	357
2017 Q4	–	Sell	-8,000	Closed	-$264K	–	613
2017 Q3	$264K	Buy	+8,000	New	+$277K	﹤0.01%	376

Other funds holding BEAT

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

HRCM

Hood River Capital Management Palm Beach Gardens, Florida $9.98B AUM 145.42% 1-Year Est. Return

Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Fred Alger Management's BEAT Position: Q1 2019 in Review

Fred Alger Management sold out of BioTelemetry, Inc. (BEAT) in Q1 2019, closing a stake of 7,000 shares — an estimated $418K sold.

Fred Alger Management first reported a position in BEAT in Q3 2017 and held it in 3 quarters. The position peaked at $540K in Q2 2018. 311 funds tracked by Wall St. Rank hold BEAT as of Q1 2019.

Fred Alger Management reported no remaining BioTelemetry, Inc. position as of Q1 2019 after selling out during the quarter.
Fred Alger Management sold 7,000 BioTelemetry, Inc. shares in Q1 2019, an estimated $418K.
Fred Alger Management first reported a position in BioTelemetry, Inc. in Q3 2017 and held it in 3 quarters.
Fred Alger Management's BioTelemetry, Inc. position peaked at $540K in Q2 2018.
311 funds tracked by Wall St. Rank held BioTelemetry, Inc. as of Q1 2019.

Based on Fred Alger Management's 13F filing for Q1 2019, filed 14 May 2019.